SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VRA (AMEX), Viragen INC. -- Ignore unavailable to you. Want to Upgrade?


To: Due Diligence who wrote (1529)12/9/1999 9:01:00 AM
From: Ga Bard  Read Replies (1) | Respond to of 1590
 
Yep it is not going to take long for it to get the public's interest. Viragen (Nasdaq: VRGN - news) develops blood-derived therapies for treating cancer and other serious ailments and has a product in Phase II European trials for Hepatitis C.

They have gotten an underwriting and more I would suspect is coming.

:-)

Gary